The Oncology Institute "Prof. Dr. Ion Chiricuţă" I.O.C.H.

Cluj-Napoca 400015

1 studies enrolling now · 1 studies all time

What they study most

Refractory Diffuse Large B-cell Lymphoma, Relapsed Diffuse Large B-cell Lymphoma

Studies at this site

• DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma — Recruiting now